Package | silth.fhir.terminology.core |
Type | CodeSystem |
Id | cs-thcc-allergy-manifest |
FHIR Version | R5 |
Source | https://terms.sil-th.org/core/https://terms.sil-th.org/core/STU1/CodeSystem-cs-thcc-allergy-manifest.html |
URL | https://terms.sil-th.org/core/CodeSystem/cs-thcc-allergy-manifest |
Version | 0.1.2 |
Status | active |
Date | 2023-10-11T23:15:12+07:00 |
Name | CS_THCC_AllergyManifest |
Title | THCC: รหัสลักษณะอาการแพ้ยาที่พบ |
Description | รหัสลักษณะอาการแพ้ยาที่พบ โดย THCC (ID: 68) |
Content | complete |
ValueSet | |
vs-thcc-allergy-manifest | THCC: รหัสลักษณะอาการแพ้ยาที่พบ |
No resources found
Note: links and images are rebased to the (stated) source
This case-insensitive code system https://terms.sil-th.org/core/CodeSystem/cs-thcc-allergy-manifest
defines the following codes:
{ "resourceType": "CodeSystem", "id": "cs-thcc-allergy-manifest", "meta": { "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablecodesystem" ] }, "text": { "status": "generated", "div": "<!-- snip (see above) -->" }, "url": "https://terms.sil-th.org/core/CodeSystem/cs-thcc-allergy-manifest", "version": "0.1.2", "name": "CS_THCC_AllergyManifest", "title": "THCC: รหัสลักษณะอาการแพ้ยาที่พบ", "status": "active", "experimental": false, "date": "2023-10-11T23:15:12+07:00", "publisher": "Standards and Interoperability Lab - Thailand (SIL-TH)", "contact": [ { "name": "Standards and Interoperability Lab - Thailand (SIL-TH)", "telecom": [ { "system": "url", "value": "https://www.sil-th.org" } ] } ], "description": "รหัสลักษณะอาการแพ้ยาที่พบ โดย THCC (ID: 68)", "caseSensitive": false, "content": "complete", "count": 39, "concept": [ { "code": "01", "display": "D59.0", "definition": "Drug-induced autoimmune hemolytic anemia" }, { "code": "02", "display": "D59.2", "definition": "Drug-induced non autoimmune hemolytic anemia" }, { "code": "03", "display": "D60.1", "definition": "Transient acquired pure red cell aplasic" }, { "code": "04", "display": "D61.1", "definition": "Drug-induced aplastic anemia" }, { "code": "05", "display": "D64.2", "definition": "Secondary sideroblastic anemia due to drugs and toxic" }, { "code": "06", "display": "D68.3", "definition": "Haemorrhagic disorders due to circulating anticoagulants" }, { "code": "07", "display": "D70", "definition": "Agranolocytosis" }, { "code": "08", "display": "G21.0", "definition": "Malignant neuroleptic syndrome" }, { "code": "09", "display": "G21.1", "definition": "Other drugs-induced secondary parkinsonism" }, { "code": "10", "display": "G25.1", "definition": "Drug-induced tremor" }, { "code": "11", "display": "G25.6", "definition": "Drug-induced tremor and other tias of organic crign" }, { "code": "12", "display": "G44.4", "definition": "Drugs - induced headocin, not elsewhere" }, { "code": "13", "display": "G72.0", "definition": "Drugs - induced myopathy classified" }, { "code": "14", "display": "G93", "definition": "Toxic encephalopathy" }, { "code": "15", "display": "H40.6", "definition": "glaucon secondary to drugs" }, { "code": "16", "display": "H26.3", "definition": "Drug-induced catarat" }, { "code": "17", "display": "I42.7", "definition": "Cardiomyopathy due to drugs and other external drugs" }, { "code": "18", "display": "I95.2", "definition": "Hypotension due to drugs" }, { "code": "19", "display": "L23.3", "definition": "Allergic contact dermatitis due to drugs in contact With skin" }, { "code": "20", "display": "L24.4", "definition": "Irritant contact dermatitis due to drugs in contact with skin" }, { "code": "21", "display": "L25.1", "definition": "Unspecified contact dermatitis due to drugs in contact with skin" }, { "code": "22", "display": "L26", "definition": "Exfoliative dermatitis" }, { "code": "23", "display": "L27.0", "definition": "Generalized skin eruption due to drugs and medicaments" }, { "code": "24", "display": "L27.10", "definition": "Fixed drugs eruption" }, { "code": "25", "display": "L27.18", "definition": "Other specified localized skin eruption due to drugs and medicaments" }, { "code": "26", "display": "L27.19", "definition": "Localized skin eruption due to drugs and medicaments, unspecified" }, { "code": "27", "display": "L50.0", "definition": "Allergic urticaria" }, { "code": "28", "display": "L50.6", "definition": "Contact urticaria" }, { "code": "29", "display": "L51.0", "definition": "Nombullous erythema multiforne" }, { "code": "30", "display": "L51.1", "definition": "Bullous erythema multiforme" }, { "code": "31", "display": "L51.8", "definition": "Other erythema multifonme" }, { "code": "32", "display": "L51.9", "definition": "Erythema multiforme, unspecified" }, { "code": "33", "display": "M10.2", "definition": "Drug-induced gout" }, { "code": "34", "display": "M62.8", "definition": "Rhabdornylysis" }, { "code": "35", "display": "M80.4", "definition": "Drug-induced osteoporosis with pathological factors" }, { "code": "36", "display": "M81.4", "definition": "Drug-induced osteoporosis" }, { "code": "37", "display": "N14.0", "definition": "Analgesic nephropatic" }, { "code": "38", "display": "N14.1", "definition": "Nephropathy induced by other drugs, medicaments and biological substuces" }, { "code": "39", "display": "N14.2", "definition": "toxic nephropathy, not elsewhere classified" } ] }